Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies

Rose P. Webster, Leslie Myatt

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.

Original languageEnglish (US)
Pages (from-to)1147-1155
Number of pages9
JournalProteomics - Clinical Applications
Volume1
Issue number9
DOIs
StatePublished - Sep 2007
Externally publishedYes

Fingerprint

Pre-Eclampsia
Proteomics
Proteome
Technology
Hydrops Fetalis
Bed Rest
Proteins
Pulse time modulation
Antihypertensive Agents
Blood pressure
Heart Diseases
Mothers
Research Personnel
Genome
Blood Pressure
Morbidity
Pregnancy
Genes
Mortality
Therapeutics

Keywords

  • Preeclampsia
  • Pregnancy
  • Vascular

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies. / Webster, Rose P.; Myatt, Leslie.

In: Proteomics - Clinical Applications, Vol. 1, No. 9, 09.2007, p. 1147-1155.

Research output: Contribution to journalArticle

Webster, Rose P. ; Myatt, Leslie. / Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies. In: Proteomics - Clinical Applications. 2007 ; Vol. 1, No. 9. pp. 1147-1155.
@article{66aba638a8cc4fe4a028a52f3d905289,
title = "Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies",
abstract = "Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the {"}proteome{"}. Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.",
keywords = "Preeclampsia, Pregnancy, Vascular",
author = "Webster, {Rose P.} and Leslie Myatt",
year = "2007",
month = "9",
doi = "10.1002/prca.200700128",
language = "English (US)",
volume = "1",
pages = "1147--1155",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies

AU - Webster, Rose P.

AU - Myatt, Leslie

PY - 2007/9

Y1 - 2007/9

N2 - Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.

AB - Preeclampsia, a disease of pregnancy, is a multisystem disorder associated with elevated maternal blood pressure, proteinurea, oedema, and fetal abnormalities. It is a major cause of mortality, morbidity, perinatal death, and premature delivery. Despite active research in the past decade, there is yet no definitive cure for preeclampsia. The disease has been treated symptomatically with antihypertensives, antieclamptics, bed rest, and a whole gamut of isolated therapies. In an attempt to understand the molecular basis of this disease and many other fatal diseases including cancer and heart disease, the scientific community has been turning to understanding the genome and more lately the "proteome". Proteomics enables researchers to identify all proteins expressed in a cell or organ and detect any PTM in the protein expression patterns. Deciphering the placental proteome and studying the differences in protein expression patterns in the normal as against the preeclamptic proteome might possibly in future lead to early detection and therapeutic targeting of preeclampsia.

KW - Preeclampsia

KW - Pregnancy

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=38349086692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349086692&partnerID=8YFLogxK

U2 - 10.1002/prca.200700128

DO - 10.1002/prca.200700128

M3 - Article

VL - 1

SP - 1147

EP - 1155

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 9

ER -